Cancer is among diseases that have been critical for many years and professionals in the healthcare industry have been working on finding solutions that could bring to an end the menace that has been affecting millions for decades. Research from various institutes has offered methods of dealing with the menace but none has managed to achieve a perfect way of dealing with cancer. This explains the reason the research to find solutions and methods of fighting the disease is still a major issue to invest in.
Experts who have been in the healthcare industry for many years like Clay Siegall also have a reason to celebrate since the achievements that have been made so far stem from the effort these professionals put to ensuring there is a cure to several diseases. Clay Siegall has been working on delivering a cure to cancer through Seattle Genetics, a company he co-founded in 1998, which has been developing drugs and conducting research to find solutions to a wide variety of diseases. Clay Siegall celebrates the success the company has achieved and the major steps he made to ensure Seattle Genetics gets to work with leading biotechnology companies like GlaxoSmithKline.
Support for cancer research
With the support he gets from his team of experts, Seattle Genetics was able to develop ADCETRIS, a drug that has been effective in the cure for cancer and treatment. He is particularly happy with the adoption and approval of the drug for use in several countries. In fact, the drug is available in more than 60 countries and they are working on to ensure its effectiveness is improved further. Additionally, Seattle Genetics has been offering young researchers an opportunity to join veterans in the journey to find solutions to various problems threatening the health of many people.
Acquiring new methods of curing cancer is a milestone that Seattle Genetics celebrates and the company has several pipelines that dwell on that area, which shows the effort that has been put to getting solutions to the menace. Clay Siegall continues to push for further effort that will see the growth of strong systems that support the development of better methods of treatment.